The groundbreaking treatment of the medication represents a significant development in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide608339.snack-blog.com/42242823/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment